Julius Berend Cohen - Related publications

1890-1924 University of Leeds, Leeds, England, United Kingdom 
Organic chemistry
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Abbasi SH, Aftab RA, Lai PSM, Lim SK, Zainol Abidin RN. Impact of Healthcare Associated Infections on Survival and Treatment Outcomes Among End Stage Renal Disease Patients on Renal Replacement Therapy. Frontiers in Pharmacology. 12: 707511. PMID 34447309 DOI: 10.3389/fphar.2021.707511   
2021 Qu F, Wu S, Zhang J. Tislelizumab combined with apatinib in the treatment of advanced renal clear cell carcinoma: a case report. Anti-Cancer Drugs. PMID 34459463 DOI: 10.1097/CAD.0000000000001241   
2021 van Tilburg CM, Pfaff E, Pajtler KW, Langenberg KPS, Fiesel P, Jones BC, Balasubramanian GP, Stark S, Johann PD, Blattner-Johnson M, Schramm K, Dikow N, Hirsch S, Sutter C, Grund K, et al. The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets. Cancer Discovery. PMID 34373263 DOI: 10.1158/2159-8290.CD-21-0094   
2021 Zhao L, Zhang CP, Wang HR, Li ZB, Liu B. [Efficacy of extracorporeal membrane oxygenation in patients with complex high risk coronary artery disease undergoing percutaneous coronary intervention]. Zhonghua Xin Xue Guan Bing Za Zhi. 49: 757-763. PMID 34404183 DOI: 10.3760/cma.j.cn112148-20210324-00270   
2021 Peiffer-Smadja N, Bridier-Nahmias A, Ferré VM, Charpentier C, Garé M, Rioux C, Allemand A, Lavallée P, Ghosn J, Kramer L, Descamps D, Yazdanpanah Y, Visseaux B. Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2. Viruses. 13. PMID 34452507 DOI: 10.3390/v13081642   
2021 Navarro-Fernandez I, Gonzalez-Vela C, Gomez-Fernandez C, Duran-Vian C, Reguero L, Gonzalez-Lopez M. Vitiligo-like Depigmentation in a Patient Undergoing Treatment with Nivolumab for Advanced Renal-cell Carcinoma. Acta Dermatovenerologica Croatica : Adc. 291: 54-55. PMID 34477066   
2021 Iqbal L, Terlau TJ, Hernandez A, Woods K. Efficacy of Bamlanivimab in Reducing Hospitalization and Mortality Rates in COVID-19 Patients in a Rural Community. Cureus. 13: e16477. PMID 34430093 DOI: 10.7759/cureus.16477   
2021 Kraft A, Croitoru A, Gheorghe C, Lupescu I, Grasu M, Tomescu D, Droc G, Herlea V, Barcu A, Popescu I, Botea F. Liver Resection for Metastases from Gastrointestinal Stromal Tumors: Does it Improve Long-Term Survival? Chirurgia (Bucharest, Romania : 1990). 116: 438-450. PMID 34498563 DOI: 10.21614/chirurgia.116.4.438   
2021 Wang TY, Yi SH, Wang Y, Lyu R, Wang Q, Deng SH, Sui WW, Fu MW, Huang WY, Liu W, An G, Zhao YZ, Qiu LG. [Clinical analysis of fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of 43 cases of chronic lymphoblastic leukemia]. Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi. 42: 543-548. PMID 34455740 DOI: 10.3760/cma.j.issn.0253-2727.2021.07.003   
2021 Brown LC, Desai K, Wei W, Kinsey EN, Kao C, George DJ, Rini BI, Ornstein MC, Zhang T. Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab. Journal For Immunotherapy of Cancer. 9. PMID 34518292 DOI: 10.1136/jitc-2021-003281   
2021 Satouchi M, Nosaki K, Takahashi T, Nakagawa K, Aoe K, Kurata T, Sekine A, Horiike A, Fukuhara T, Sugawara S, Umemura S, Saka H, Okamoto I, Yamamoto N, Sakai H, et al. First-Line Pembrolizumab Versus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer: KEYNOTE-024 Japan Subset. Cancer Science. PMID 34543477 DOI: 10.1111/cas.15144   
2021 McCoy J, Goren A, Cadegiani FA, Vaño-Galván S, Kovacevic M, Situm M, Shapiro J, Sinclair R, Tosti A, Stanimirovic A, Fonseca D, Dorner E, Onety DC, Zimerman RA, Wambier CG. Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial. Frontiers in Medicine. 8: 668698. PMID 34350193 DOI: 10.3389/fmed.2021.668698   
2021 Atif M, Naseem M, Sarwar S, Mukhtar S, Malik I, Hassan MRU, Iqbal MN, Ahmad N. Spectrum of Microorganisms, Antibiotic Resistance Pattern, and Treatment Outcomes Among Patients With Empyema Thoracis: A Descriptive Cross-Sectional Study From the Bahawal Victoria Hospital Bahawalpur, Punjab, Pakistan. Frontiers in Medicine. 8: 665963. PMID 34422850 DOI: 10.3389/fmed.2021.665963   
2021 Patrone R, Velotti N, Masone S, Conzo A, Flagiello L, Cacciatore C, Filardo M, Granata V, Izzo F, Testa D, Avenia S, Sanguinetti A, Polistena A, Conzo G. Management of Low-Risk Thyroid Cancers: Is Active Surveillance a Valid Option? A Systematic Review of the Literature. Journal of Clinical Medicine. 10. PMID 34441866 DOI: 10.3390/jcm10163569   
2021 Nasrullah A, Jayakrishnan T, Wedgeworth P, Mosley M, Vashistha K, Haag A, Bakalov V, Chaturvedi A, Manzi S, Kapetanos A. Characteristics and Outcomes of COVID-19 Patients Admitted to Intensive Care Units in a Large Health System in Western Pennsylvania. Cureus. 13: e16552. PMID 34430159 DOI: 10.7759/cureus.16552   
2021 Işık F, Çap M, Akyüz A, Bilge Ö, Aslan B, İnci Ü, Kaya İ, Taştan E, Okşul M, Çap NK, Karagöz A, Baysal E. The effect of resistant hypertension on in-hospital mortality in patients hospitalized with COVID-19. Journal of Human Hypertension. PMID 34354253 DOI: 10.1038/s41371-021-00591-8   
2021 Principe DR, Underwood PW, Korc M, Trevino JG, Munshi HG, Rana A. The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy. Frontiers in Oncology. 11: 688377. PMID 34336673 DOI: 10.3389/fonc.2021.688377   
2021 Gordon MS, Nemunaitis J, Barve M, Wainberg ZA, Hamilton EP, Ramanathan RK, Sledge GW, Yue H, Morgan-Lappe SE, Blaney M, Kasichayanula S, Motwani M, Wang L, Naumovski L, Strickler JH. Phase 1 open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of dilpacimab in patients with advanced solid tumors. Molecular Cancer Therapeutics. PMID 34315767 DOI: 10.1158/1535-7163.MCT-20-0985   
2021 Ao G, de Miguel M, Gomes A, Liu R, Boni V, Moreno I, Cárdenas JM, Cubillo A, Ugidos L, Calvo E. Toxicity and antitumor activity of novel agents in elderly patients with cancer included in phase 1 studies. Investigational New Drugs. PMID 34287771 DOI: 10.1007/s10637-021-01150-1   
2021 Ali Khan M, Haider MS, Nusrat B, Abbas Razvi SK, Shah ZZ, Shah AM, Khalid T, Haleem F. Demographics, Biochemical Characteristics, and Phases of Chronic Hepatitis B Virus Infection: Retrospective Analysis From a Secondary Care Setup. Cureus. 13: e16558. PMID 34430162 DOI: 10.7759/cureus.16558   
2021 Telles JP, Fernandes R, Barros TD, Maestri A, Vitoriano T, Borges L, Teixeira R, Marcusso R, Haziot M, De Oliveira AP, Vidal JE. Neurological manifestations in people living with HIV/AIDS in the late cART era: a prospective observational study at a tertiary healthcare center in São Paulo, Brazil. Hiv Research & Clinical Practice. 1-9. PMID 34529920 DOI: 10.1080/25787489.2021.1975609   
2021 Han HX, Cao XX, Su W, Shen KN, Zhang L, Zhou DB, Li J. [Clinical characteristics and outcome of patients with type Ⅱ cryoglobulinemia]. Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi. 42: 447-451. PMID 34384149 DOI: 10.3760/cma.j.issn.0253-2727.2021.06.002   
2021 Florou V, Puri S, Garrido-Laguna I, Wilky BA. Considerations for immunotherapy in patients with cancer and comorbid immune dysfunction. Annals of Translational Medicine. 9: 1035. PMID 34277835 DOI: 10.21037/atm-20-5207   
2021 Aratani S, Sugano T, Shimizu A, Seike M, Kashiwagi T, Gemma A, Sakai Y. Clinicopathological characteristics of kidney injury in non-small cell lung cancer patients under combination therapy including pembrolizumab. Cen Case Reports. PMID 34406602 DOI: 10.1007/s13730-021-00636-4   
2021 Zou P, Zhou M, Wen J, Liao X, Shen Y, Liu H, Song L, Xiao J. The long-term outcome and risk factors for precursor B cell acute lymphoblastic leukemia without specific fusion genes in Chinese children: experiences from multiple centers. Bosnian Journal of Basic Medical Sciences. PMID 34392828 DOI: 10.17305/bjbms.2021.5879   
2021 Topcu A, Atci MM, Secmeler S, Besiroglu M, Ayhan M, Ozkan M, Bozkurt O, Urakci Z, Ay S, Geredeli C, Yasin AI, Turk HM. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. Future Oncology (London, England). PMID 34323116 DOI: 10.2217/fon-2021-0398   
2021 Xu Y, Zheng M, Guo Q, Wang N, Wang R. Clinical Features and Survival Outcome of Early-Stage Primary Pulmonary MALT Lymphoma After Surgical Treatment. Frontiers in Surgery. 8: 713748. PMID 34422896 DOI: 10.3389/fsurg.2021.713748   
2021 Schaarschmidt BM, Wildgruber M, Kloeckner R, Nie J, Steinle V, Braat AJAT, Lohoefer F, Kim HS, Lahner H, Weber M, Theysohn J. Y radioembolization in the treatment of neuroendocrine neoplasms: Results of an international multicenter retrospective study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 34475236 DOI: 10.2967/jnumed.121.262561   
2021 Bertani L, Barberio B, Tricò D, Zanzi F, Maniero D, Ceccarelli L, Marsilio I, Coppini F, Lorenzon G, Mumolo MG, Zingone F, Costa F, Savarino EV. Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak. Journal of Clinical Medicine. 10. PMID 34362053 DOI: 10.3390/jcm10153270   
2021 Vannucchi AM, Mortara A, D'Alessio A, Morelli M, Tedeschi A, Festuccia MB, Monforte AD, Capochiani E, Selleri C, Simonetti F, Saracino A, Rapezzi D, Badagliacca MR, Falasca K, Molteni A, et al. JAK Inhibition with Ruxolitinib in Patients with COVID-19 and Severe Pneumonia: Multicenter Clinical Experience from a Compassionate Use Program in Italy. Journal of Clinical Medicine. 10. PMID 34442045 DOI: 10.3390/jcm10163752   
2021 Akizawa T, Nobori K, Matsuda Y, Taki K, Hayashi Y, Hayasaki T, Yamamoto H. Molidustat for the treatment of anemia in Japanese patients undergoing peritoneal dialysis: a single-arm, open-label, phase 3 study. Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society For Apheresis, the Japanese Society For Apheresis, the Japanese Society For Dialysis Therapy. PMID 34310049 DOI: 10.1111/1744-9987.13713   
2021 Palareti G, Legnani C, Antonucci E, Testa S, Mastroiacovo D, Cosmi B, Poli D, Bucherini E, Dentali F, Fontanella A, Mumoli N, Imberti D, Falanga A, Ageno W, Pomero F. Management and Outcomes of Isolated Distal Deep Vein Thromboses: A Questionable Trend toward Long-Lasting Anticoagulation Treatment. Results from the START-Register. Th Open : Companion Journal to Thrombosis and Haemostasis. 5: e239-e250. PMID 34263110 DOI: 10.1055/s-0041-1730038   
2021 Costa LJ, Davies FE, Monohan GP, Kovacsovics TJ, Burwick N, Jakubowiak AJ, Kaufman JL, Hong WJ, Dail M, Salem AH, Yang X, Al Masud A, Munasinghe WP, Ross JA, Bueno OF, et al. Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma. Blood Advances. PMID 34470049 DOI: 10.1182/bloodadvances.2020004146   
2021 Miles B, Mackey JD. Increased Risk of Second Primary Malignancy and Mortality at ten Years After Stem Cell Transplant for Multiple Myeloma: An Analysis of 14,532 Patients. Cureus. 13: e16372. PMID 34422458 DOI: 10.7759/cureus.16372   
2021 Mingot-Castellano ME, Pardos-Gea J, Haya S, Bastida JM, Tassies D, Marco-Rico A, Núñez R, García-Candel F, Fernandez-Sanchez de Mora MC, De La Puerta R, Soto-Ortega I, Álvarez-Roman MT, Asenjo S, Carrasco M, Lluch García R, et al. Management of acquired hemophilia A: results from the Spanish Registry. Blood Advances. PMID 34521101 DOI: 10.1182/bloodadvances.2021004626   
2021 García-Alvarado FJ, Muñoz-Hernández MA, Moran Guel E, González-Martínez MDR, Macías Corral MA, Delgado-Aguirre HA. Risk Factors and Clinical Phenotypes Associated with Severity in Patients with COVID-19 in Northeast Mexico. Vector Borne and Zoonotic Diseases (Larchmont, N.Y.). PMID 34255563 DOI: 10.1089/vbz.2021.0016   
2021 Almonte M, Au XY, Ali M, Rajabalee N, Hasan S, Shibre T, Li Y, Kaplan AC. Association Between COVID-19 Outcomes and Patient Characteristics: A Study in an Inner-City Community Hospital. Cureus. 13: e17255. PMID 34540480 DOI: 10.7759/cureus.17255   
2021 Thielmann M, Corteville D, Szabo G, Swaminathan M, Lamy A, Lehner LJ, Brown CD, Noiseux N, Atta MG, Squiers EC, Erlich S, Rothenstein D, Molitoris B, Mazer CD. Teprasiran, A Small Interfering RNA, for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery: A Randomized Clinical Study. Circulation. PMID 34474590 DOI: 10.1161/CIRCULATIONAHA.120.053029   
2021 Moeller M, Adner J, Schuette W, Krueger M. [30- and 90-day Lethality in Patients with Stage IV Lung Cancer Depending on the Primary Therapy]. Pneumologie (Stuttgart, Germany). PMID 34298565 DOI: 10.1055/a-1534-1339   
2021 Landsburg DJ, Barta SK, Ramchandren R, Batlevi C, Iyer S, Kelly K, Micallef IN, Smith SM, Stevens DA, Alvarez M, Califano A, Shen Y, Bosker G, Parker J, Soikes R, et al. Fimepinostat (CUDC-907) in patients with relapsed/refractory diffuse large B cell and high-grade B-cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses. British Journal of Haematology. PMID 34341990 DOI: 10.1111/bjh.17730   
2021 Zhou ZB, Hua ZH, Xu P, Cao H, Liu SR, Yue YQ, Zhang Q, Zhang S, Ma K, Li Z. [Analysis of diagnosis, treatment and risk classification of blunt thoracic aortic injury]. Zhonghua Yi Xue Za Zhi. 101: 2293-2298. PMID 34333944 DOI: 10.3760/cma.j.cn112137-20210608-01312   
2021 Feeney L, Jain Y, Beasley M, Donnelly O, Kong A, Moleron R, Nallathambi C, Rolles M, Sanghera P, Tin A, Ulahannan D, Walter HS, Webster R, Metcalf R. Centralised RECIST Assessment and Clinical Outcomes with Lenvatinib Monotherapy in Recurrent and Metastatic Adenoid Cystic Carcinoma. Cancers. 13. PMID 34503145 DOI: 10.3390/cancers13174336   
2021 Suarez-Cuartin G, Gasa M, Bermudo G, Ruiz Y, Hernandez-Argudo M, Marin A, Trias-Sabria P, Cordoba A, Cuevas E, Sarasate M, Ariza A, Sabater J, Romero N, Subirana C, Molina-Molina M, et al. Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit. Frontiers in Medicine. 8: 711027. PMID 34277674 DOI: 10.3389/fmed.2021.711027   
2021 Russick J, Foy PE, Josseaume N, Meylan M, Hamouda NB, Kirilovsky A, Sissy CE, Tartour E, Smadja DM, Karras A, Hulot JS, Livrozet M, Fayol A, Arlet JB, Diehl JL, et al. Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine. Frontiers in Immunology. 12: 701273. PMID 34322128 DOI: 10.3389/fimmu.2021.701273   
2021 Bastola A, Shrestha S, Nepal R, Maharjan K, Shrestha B, Chalise BS, Thapa P, Balla P, Sapkota A, Shah P. Clinical Mortality Review of COVID-19 Patients at Sukraraj Tropical and Infectious Disease Hospital, Nepal; A Retrospective Study. Tropical Medicine and Infectious Disease. 6. PMID 34287389 DOI: 10.3390/tropicalmed6030137   
2021 Yang X, Zhou K, Tao Y, Ge S, Shang W, Song K. Treatment efficacy and prognosis of pulmonary metastasizing ameloblastoma: a systematic review. International Journal of Oral and Maxillofacial Surgery. PMID 34462177 DOI: 10.1016/j.ijom.2021.07.016   
2021 Kawata T, Ikeda A, Masuda H, Komatsu S. Association Between Albumin-Bilirubin Score at Admission and In-Hospital Mortality in Patients with Acute Heart Failure. International Heart Journal. 62: 829-836. PMID 34276023 DOI: 10.1536/ihj.21-080   
2021 Mummudi N, Jiwnani S, Niyogi D, Srinivasan S, Ghosh-Laskar S, Tibdewal A, Rane P, Karimundackal G, Pramesh CS, Agarwal JP. Salvage radiotherapy for postoperative locoregional failure in esophageal cancer: a systematic review and meta-analysis. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus. PMID 33912933 DOI: 10.1093/dote/doab020   
2021 Ando Y, Kawaoka T, Kosaka M, Shirane Y, Johira Y, Miura R, Murakami S, Yano S, Amioka K, Naruto K, Kosaka Y, Uchikawa S, Kodama K, Fujino H, Nakahara T, et al. Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice. Cancers. 13. PMID 34439111 DOI: 10.3390/cancers13163958   
2021 Doi T, Yamamoto N, Naito Y, Kuboki Y, Koyama T, Piao Y, Tsujimoto N, Asou H, Inoue K, Kondo S. Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 study. Cancer Medicine. PMID 34499416 DOI: 10.1002/cam4.4110